Functionalisation of a heat-derived and bio-inert albumin hydrogel with extracellular matrix by air plasma treatment by Ong, John et al.
1Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:12429  | https://doi.org/10.1038/s41598-020-69301-7
www.nature.com/scientificreports
functionalisation of a heat‑derived 
and bio‑inert albumin hydrogel 
with extracellular matrix by air 
plasma treatment
John ong1,2,3,5*, Junzhe Zhao1,4,5, Galit Katarivas Levy1, James Macdonald1, 
Alexander W. Justin1 & Athina E. Markaki1*
Albumin‑based hydrogels are increasingly attractive in tissue engineering because they provide a 
xeno-free, biocompatible and potentially patient-specific platform for tissue engineering and drug 
delivery. The majority of research on albumin hydrogels has focused on bovine serum albumin (BSA), 
leaving human serum albumin (HSA) comparatively understudied. Different gelation methods are 
usually employed for HSA and BSA, and variations in the amino acid sequences of HSA and BSA exist; 
these account for differences in the hydrogel properties. Heat-induced gelation of aqueous HSA is the 
easiest method of synthesizing HSA hydrogels however hydrogel opacity and poor cell attachment 
limit their usefulness in downstream applications. Here, a solution to this problem is presented. 
Stable and translucent HSA hydrogels were created by controlled thermal gelation and the addition 
of sodium chloride. the resulting bio‑inert hydrogel was then subjected to air plasma treatment 
which functionalised its surface, enabling the attachment of basement membrane matrix (Geltrex). 
In vitro survival and proliferation studies of foetal human osteoblasts subsequently demonstrated 
good biocompatibility of functionalised albumin hydrogels compared to untreated samples. Thus, air 
plasma treatment enables functionalisation of inert heat‑derived HSA hydrogels with extracellular 
matrix proteins and these may be used as a xeno‑free platform for biomedical research or cell therapy.
Albumin is an abundant non-glycosylated, 66.4 kDa protein in human serum that has a physiological half-life 
of approximately 19 days. It is synthesized predominantly by hepatocytes and poorly excreted through the renal 
 glomerulus1. Being poorly metabolised and weakly immunogenic, it is stable in vivo. Albumin is also versatile, 
acting as a weak pH buffer, and as a stabiliser to important proteins, hormones, metal ions, nanoparticles and 
drugs, making it an attractive biomaterial. These desirable attributes have led to extensive research into albumin 
as a protein conjugate for drug delivery and  pharmacotherapy1–3. However, the use of albumin-based hydrogels 
in biomedical research is comparatively under-studied4.
Recently, we demonstrated that human serum albumin (HSA) embedded in a fibrin hydrogel significantly 
promoted osteoblast differentiation and vascular self-organisation of human endothelial  cells5. However, high 
cell numbers  (106 cells/ml or greater) degrade these fibrin-based hydrogels within 8–10 days making it unsuitable 
for studying long term bone development and implantation into animal models. Furthermore, it was anticipated 
that the implantation of fibrin-based scaffolds into bone would accelerate its degradation in vivo because of the 
presence of serum fibrinolytics and movement of bone during locomotion. Therefore, albumin-based hydrogels 
were explored as an alternative material for scaffolds. Heat-derived bovine serum albumin (BSA) hydrogels 
(20% w/v) exhibit high Young’s modulus (~ 55 kPa) and longer degradation periods (~ 4 to 8 weeks) in vitro and 
in vivo, however they are completely  opaque6. Unfortunately there is a paucity of data on heat-derived HSA and 
approximately 75% of all studies on albumin hydrogels have been conducted on bovine serum albumin (BSA)4. 
This is problematic because BSA and HSA only share 76% similarity in amino acid sequences and this accounts 
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for different properties between the two  proteins7,8. For example, Arabi et al.9 demonstrated that 20% (w/v) HSA 
and 20% (w/v) BSA solutions have non-identical phase diagrams at acidic pH. Therefore, observations made 
with BSA hydrogels cannot be directly extrapolated to HSA hydrogels.
Albumin hydrogels are usually derived by three main methods: heat induced gelation, pH induced gelation 
and chemical crosslinking. Each method affects the properties of the resulting hydrogels, e.g. gelation precipitated 
by strongly acidic or strongly alkali pH produces transparent albumin hydrogels whereas heat induced gelation 
produces an opaque hydrogel with larger pore sizes and a longer biodegradation  time6,10. The most commonly 
used method is chemical crosslinking, often with glutaraldehyde or conjugated with functionalised polyethylene 
glycol (PEG)4. However these processes are laborious, costly and the resulting scaffolds can be  immunogenic4,11. 
Heat-induced gelation is by far the easiest method to synthesize albumin hydrogels, however the opacity of 
resulting hydrogels precludes normal microscopy often required for cell and tissue culture. In addition, con-
formational differences at various pHs and temperatures restrict protein binding sites contributing to poor cell 
attachment onto hydrogel surfaces.
In order for heat-derived HSA hydrogels to be useful for biological applications, novel methods to improve 
better hydrogel clarity and cell attachment are required. To that end, we successfully adapted a  method12 pre-
viously used to obtain transparent BSA hydrogels with the addition of sodium chloride (NaCl) to produce 
translucent albumin hydrogels. However despite achieving sufficient hydrogel clarity, cell attachment to heat-
derived albumin hydrogel surfaces remained poor. Therefore, functionalisation of hydrogel surfaces by air plasma 
treatment was explored because of the limited flexibility within the thermal gelation method. During air plasma 
treatment, atmospheric gases such as oxygen, hydrogen or nitrogen, are ionised with a strong radio-frequency 
(RF) electromagnetic field to form a non-thermal plasma. Electrons are excited to very high temperatures 
(~ 105–106 K) while collisions with the background ions maintain the plasma at near ambient temperatures 
 overall13. These charged species introduce reactive groups onto the surfaces of polymeric materials such as 
carbonyl, carboxyl and hydroxyl functionalities. Consequently, these functional groups can bind extracellular 
matrices or cell surface proteins onto the plasma-treated surface.
While plasma-activated bonding has become a routine procedure in the assembly of microfluidic devices 
and microelectromechanical systems (MEMS), the treatment of tissue engineering scaffolds with plasma is 
still gaining attention, particularly in bone tissue  engineering14–20. Biomaterials such as silk, gelatin, chitosan, 
hydroxyapatite, calcium phosphate and polycaprolactone have been successfully plasma treated, however, to the 
best of our knowledge, plasma treatment of albumin hydrogels has not been previously reported. Importantly, 
unlike these materials HSA offers added advantages of being a xeno-free polymer that can be patient derived 
for easier transition into downstream clinical applications such as platforms for cell therapy, drug delivery or 
scaffolds for tissue engineering.
Therefore, the aims of this work were to (1) create a translucent heat-derived HSA hydrogel and (2) improve 
cell attachment to heat-derived HSA hydrogels by functionalising them with bioactive, extracellular matrices. 
Below, novel methods for obtaining translucent HSA hydrogels and their functionalisation by air plasma treat-
ment are described. The successful coating of heat-derived HSA hydrogels with basement membrane matrix 
(Geltrex) and the stable culture of foetal human osteoblasts (fHObs) in vitro are then demonstrated on plasma 
treated, matrix-coated hydrogels and not on untreated, matrix-coated hydrogels. The results herein provide 
proof of concept that heat-derived HSA hydrogels can be functionalised inexpensively by air plasma treatment, 
providing a xeno-free biocompatible material for biomedical research, especially for tissue engineering and 
emerging cell therapies.
Results
Type of solvent, HSA concentration, heating temperatures and duration affected hydrogel 
opacity. HSA was dissolved in solutions with different ionic content: deionised water (DI), Dulbecco’s Phos-
phate Buffered Saline (PBS) and Dulbecco’s Modified Eagle Medium nutrient mixture F-12 (DMEM/F12), at a 
pH range suitable for normal cell culture (pH 7.1─7.4). Controlled heat was then applied to the solutions fol-
lowed by air plasma treatment and surface coating as illustrated in Fig. 1a. Briefly, hydrogel opacity increased 
with increasing albumin concentration and 10% w/v HSA was found to be optimal for hydrogel clarity (Sup-
plementary Table S1). Screening experiments further demonstrated that heating aqueous solutions of 10% w/v 
albumin above 75 °C for 60 min produced clear to translucent HSA-DI hydrogels, but opaque HSA-PBS and 
HSA-DMEM/F12 hydrogels, rendering the latter two hydrogels unsuitable for bright-field microscopy and 
cell culture. Heating at 70–75  °C for 60  min resulted in clear HSA-DI hydrogels, translucent HSA-DMEM/
F12 hydrogels and opaque HSA-PBS hydrogels (Fig. 1b, left panel). Below 70 °C, all three solutions failed to gel 
within 60 min. An array of gelation conditions was determined (Supplementary Table S2) and the optimal heat-
ing temperature and duration that produced mechanically stable hydrogel were found to be 70–75 °C and four 
hours respectively.
Addition of sodium chloride improved the resilience of HSA-DMEM/F12 hydrogels. Although 
HSA-DI and HSA-PBS hydrogels were obtained under optimal conditions, these were prone to damage during 
and after plasma treatment (Fig. 1b, right panel). HSA-DMEM/F12 hydrogels, although weak, were resistant to 
fracturing during plasma treatment, however these were still damaged within 1–3 days of cell culture. Previ-
ously, Murata et  al.12 demonstrated that the addition of sodium chloride to BSA solutions could reduce the 
opacity of heat-derived BSA hydrogels and facilitate gelation. In this study, it was observed that the addition of 
30 mM NaCl to HSA-DMEM/F12, raising the final NaCl concentration to 150 mM, did not result in a noticeable 
improvement to hydrogel transparency, however it increased hydrogel strength which allowed mechanical test-
ing to be performed subsequently. A significant reduction in fractures during plasma treatment and cell culture 
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Figure 1.  (a) Schematic representation of hydrogel preparation and functionalisation. (b) Hydrogels formed by 
dissolving HSA in DMEM/F12 with additional sodium chloride (top left), DMEM/F12 (top right), PBS (bottom 
left) and DI (bottom right). Left panel: before plasma treatment, right panel: after plasma treatment. Black dots 
printed on paper beneath the well-plate to demonstrate hydrogel opacity. Black arrows point at regions where 
the hydrogels failed after plasma treatment. (c) SEM images of HSA-DMEM/F12 hydrogel surfaces; plasma-
treated and non-plasma treated surfaces.
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were also noted in HSA-DMEM/F12 hydrogels enriched with NaCl. Optical clarity of HSA-PBS hydrogels and 
the stability of HSA-DI hydrogels were not improved by the addition of NaCl to both solvents (Supplementary 
Table S3).
Plasma treatment affects surface roughness of HSA-DMEM/F12 hydrogels. Images obtained 
by scanning electron microscopy (SEM) demonstrated that plasma treatment increased the surface roughness 
of heat derived HSA-DMEM/F12 hydrogels whereas untreated surfaces had a smoother but porous surface 
(Fig. 1c). Profile roughness parameters (Ra) obtained by interferometry also confirmed a significant difference 
between plasma treated and non-plasma treated HSA-DMEM/F12 hydrogel surfaces as shown in Fig. 2a. None-
theless, both hydrogels were observed to have hydrophilic surfaces with sessile water droplet contact angles 
below 90°. Plasma treated surfaces, however, were observed to have smaller contact angles than untreated sur-
faces, suggesting the former is more hydrophilic; 45.7° ± 5.3° vs. 66.8° ± 1.6° respectively, p < 0.001 (Supplemen-
Figure 2.  (a) Reconstructed surface images of plasma-treated and untreated HSA-DMEM/F12 hydrogels with 
interferometry. Plasma-treated surfaces are significantly rougher than untreated surfaces, Ra values expressed 
as mean ± standard deviation, ***p < 0.001. (b) Stress–strain curves of plasma-treated and untreated HSA-
DMEM/F12 hydrogels with the calculated Young’s moduli. Values represent mean ± standard error. No statistical 
difference was detected between both groups.
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tary Table S4). Young’s modulus measurements show that untreated and plasma treated HSA-DMEM hydrogels 
have similar Young’s moduli; 2.34 ± 0.54 kPa vs. 2.87 ± 0.27 kPa respectively, p = 0.51 (Fig. 2b).
Plasma treatment enables the coating of HSA-DMEM/F12 hydrogel with basement mem‑
brane proteins. Plasma-treated HSA-DMEM/F12 hydrogels coated with basement membrane proteins 
(Geltrex), facilitated good attachment of fHObs and supported cell growth (Fig. 3a). Without a surface coating 
of Geltrex, cell attachment of fHObs on plasma treated HSA-DMEM hydrogel was poor (Fig. 3b). After 6 days of 
cell culture, cell numbers compared to the initial seeding density on plasma-treated Geltrex-coated HSA-DMEM 
hydrogels had a mean fold increase of 6.3 ± 0.5. However, cell numbers on plasma-treated uncoated HSA-DMEM 
hydrogels were observed to be less than the original seeding density: mean fold increase = 0.3 ± 0.1. Differences 
were statistically significant (p < 0.001). Despite extended cell culture of 8 days, cell confluence remained poor 
in plasma-treated, uncoated surfaces and fHObs continued to detach with every routine medium change. On 
non-plasma treated HSA-DMEM/F12 hydrogels, attachment of fHObs to Geltrex coated (Fig. 3c) and uncoated 
(Fig. 3d) hydrogel surfaces were extremely poor. 48 h after plating fHObs onto these surfaces, no cells remained. 
These results demonstrate that surface coating of Geltrex onto plasma treated DMEM-HSA hydrogel surfaces 
was adequately achieved, which allowed the attachment and proliferation of fHObs.
fHObs cultured on plasma-treated Geltrex-coated HSA hydrogels maintained common osteo‑
blastic signatures. High expression of actin is observed in human  osteoblasts21 and low actin expression 
is observed in undifferentiated human embryonic stem cells (hESCs)22. Similarly, high vinculin expression is 
indicative of good osteoblasts  adhesion23 and vinculin is poorly expressed in stem cells on compliant substrates 
(< 200 kPa)24,25. Comparisons of fluorescent intensities between fHObs and hESCs cultured on plasma-treated, 
Geltrex-coated HSA-DMEM/F12 hydrogels demonstrated strongly positive actin and vinculin staining in 
fHObs and conversely poor staining in hESCs (Fig. 4). Further analysis of fHObs cultured on plasma-treated 
Geltrex-coated HSA hydrogels at Day 8 for alkaline phosphatase (ALP), collagen-1 alpha 1 (COL1A1), osteoc-
alcin (OCN) and runt-related transcription factor 2 (RUNX2), demonstrated preserved and higher gene expres-
sion profiles of these commonly expressed osteoblast genes when compared to fHObs cultured on tissue culture 
treated surfaces at Day 1 (Fig. 5).
Discussion
The resulting Young’s modulus of translucent HSA-DMEM/F12 hydrogels is significantly lower than opaque 
BSA-PBS hydrogels previously reported; ~ 3 kPa vs. ~ 55kPa6 respectively. This is most likely caused by differences 
in the albumin protein and the concentration that was used for hydrogel synthesis. Although HSA hydrogels 
Figure 3.  Serial bright field microscopy of fHObs seeded on HSA-DMEM/F12 hydrogels: (a) plasma-treated 
and Geltrex coated surface, (b) plasma-treated and uncoated surface, (c) non-plasma treated but Geltrex 
coated surface and (d) non-plasma treated and uncoated surface. No cells adhered to (c) and (d) after 48 h. Cell 
attachment in (b) was poor throughout. Scale bar: 100 µm.
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Figure 4.  Immunofluorescence imaging and image analysis of fHObs and hESCs cultured on plasma-treated 
and Geltrex-coated HSA-DMEM/F12 hydrogels. Cytoplasmic staining of actin (green) and vinculin (red). 
Nuclear staining with DAPI (blue). Statistically significant differences were displayed as ***p < 0.001, and derived 
by independent t-tests. Data represented as mean ± standard deviation from three independent experiments.
Figure 5.  Gene expression analysis of fHObs cultured on plasma-treated, matrix-coated (PTMC) HSA-DMEM/
F12 hydrogels at day 8 of culture (a) ALP, (b) COL1-A1, (c) OCN and (d) RUNX2. Control samples are fHObs 
cultured on tissue cultured treated plates and harvested at Day 1. Due to poor cell attachment, insufficient RNA 
was extracted from fHObs cultured on plasma-treated, uncoated HSA-DMEM/F12 hydrogels. Statistically 
significant differences were displayed as **p < 0.01, and derived by independent t-tests. Data represented as 
mean ± standard deviation.
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were initially investigated for durability, this study prioritised optical clarity over the stiffness of HSA hydrogels 
to increase its usefulness in biomedical research. A Young’s modulus of 3 kPa is identical to the stiffness of many 
organs in the human body but it is significantly less than bone (trabecular bone ~  ≥ 10GkPa). Nonetheless, 
these scaffolds remain applicable to research in bone and examples of their potential uses are discussed below. 
Importantly, the methods described herein above provide a novel, uncomplicated and inexpensive alternative to 
chemically crosslinking albumin hydrogels which can cause various degrees of local inflammation and fibrous 
capsule formation after  implantation26,27.
Ionic content affects hydrogel properties and we observed that increasing the ionic content of HSA-DMEM/
F12 by the addition of NaCl significantly improved the rate of gelation and hydrogel strength. In addition, a 
positive effect was noted when NaCl was added to DI, however this was to a much lesser extent; resulting HSA-
DI hydrogels were still prone to damage after handling and air plasma treatment (Supplementary Table S3). 
Unfortunately, increasing NaCl concentrations resulted in increasing opacity across all hydrogels types. The 
mechanism of gelation for heat-derived albumin hydrogels are well described in  literature28–31, and the differences 
observed between these three hydrogels are most likely explained by the differences in ionic content and concen-
trations in all three solvents. However, it was not feasible to determine the effect of specific ions on gelation and 
hydrogel clarity because of the sheer multitude of permutations between ion combinations and concentrations. 
For example, DMEM/F12 contains up to sixty eight different constituents at varying concentrations. Therefore, 
only the optimal conditions were described herein.
Our results demonstrated that air plasma treatment alters the surface properties of heat-derived albumin 
hydrogels allowing functionalisation with target proteins. Importantly, we observed that the degree of air plasma 
treatment, both intensity and duration of treatment, significantly influenced the degree of functionalisation 
and hydrogel appearance (Supplementary Table S5). ’Over-treatment’ caused macroporous hydrogels which 
obliterated cell visibility on bright-field microscopy, and ’under-treatment’ led to poor functionalisation and 
cell attachment. It was also observed that the bulk of the hydrogels were influenced by the plasma treatment 
conditions. While HSA-DI hydrogels were readily damaged during handling even before the plasma treatment, 
both HSA-PBS hydrogels and HSA-DMEM/F12 hydrogels without NaCl became more prone to damage after 
the treatment. The difference in ionic content is an important factor in accounting for these differences but the 
formation of cracks may also be attributed to the fact that air plasma treatment involves rapid changes in tem-
perature, pressure, and potential surface damage from energetic plasma ions. Nonetheless, a limitation of this 
method is that functionalisation occurs superficially. As a result, the bulk of the hydrogel may remain inert and 
conjugation of proteins within the albumin hydrogel may not occur. To overcome this limitation, functionalised 
3D constructs can be created from assembled planar components. For example, thin albumin hydrogel sheets 
with a patterned surface could be created through sacrificial moulding, plasma treated, coated with selected 
matrix proteins, then adhered together with human fibrin to create a 3D construct with organised interconnect-
ing spaces. Such scaffolds could then be investigated for further use in bone disease such as non-union of long 
bone fractures or in reducing aseptic loosening in bone prostheses.
Similarly, 3D porous constructs have been used in liver tissue engineering to optimise cell delivery for bridg-
ing therapy in liver failure, disease modelling and drug studies. These are typically made from PEG and coated 
with extracellular matrix proteins. Although they have been shown to improve hepatocyte  function32–34, the bio-
degradability and acquired immunogenicity of PEG  scaffolds11 in vivo remain outstanding issues. The observed 
Young’s modulus of HSA-DMEM/F12 hydrogels (2.87 ± 0.27 kPa) was found to be similar to the normal stiffness 
of human liver tissue which is approximately 2–6  kPa35–37. Therefore, HSA-DMEM/F12 hydrogels may pro-
vide an alternative to synthetic or de-cellularised liver scaffolds since they are xeno-free, patient-derivable and 
mimic normal liver stiffness. Apart from the liver, HSA-DMEM/F12 scaffolds may also be used for drug studies 
and modelling tissue growth for the human heart. Although native heart tissue has higher stiffness than HSA-
DMEM/F12 hydrogels, several studies have reported that matrix-coated albumin hydrogels (derived by more 
laborious methods of electro-spinning and pH induced gelation) have a positive effect on neonatal ventricular 
rat cardiomyocytes and human cardiomyocytes derived from induced pluripotent stem cells when compared to 
conventional 2D culture  methods38–41.
Cell behaviour and function are critically affected by extracellular cues known as the ’niche’ which includes 
extracellular matrix proteins. For bone, laminins and collagen play an integral part of the bone marrow niche 
which influences bone development and regeneration. For this reason, Geltrex was used as a coating matrix in 
this study since laminins and collagen are components of Geltrex. Laminins, through various integrin bind-
ing sites, suppress osteoclastogenic  activity42, promote bone marrow mesenchymal stromal cell adhesion and 
 growth43, and enhance osteogenic  differentiation44. Likewise, collagen has also been reported to enhance osteo-
genic  differentiation44. An important observation of this study is that plasma treated, matrix-coated albumin 
hydrogels supported the in vitro attachment and expansion of fHObs similarly. Immunostaining demonstrated 
expectedly high expression of actin and vinculin in fHObs when compared to HESCs. HESCs were used as a 
comparison because expression of these proteins are low in undifferentiated stem cells, and also because other 
cell types such as fibroblasts can express high levels of actin and vinculin.
In vitro studies have demonstrated that osteoblasts exhibit a gradient of maturity and cell  behaviour45,46. These 
are affected by factors including, but not limited to, the region of bone and donor  age47. The presence of actin 
and vinculin, in addition to the higher gene expression of COL-1A1, ALP, OCN and RUNX2 in fHObs cultured 
on plasma-treated, Geltrex-coated albumin hydrogels, suggest that fHObs adhered to the surface-coated matrix 
and this resulted in the observed effect. These early data suggest that Geltrex may enhance the differentiation 
of immature fHObs towards a more mature phenotype. In particular, RUNX2 is a transcription factor that is 
critical for osteoblast proliferation and differentiation, especially during the exit of preosteoblasts from the cell 
cycle and during the maturation of  osteoblasts48,49. In the latter, RUNX2 expression increases as cells differentiate 
from osteoprogenitors, to immature osteoblasts, and remains up-regulated to at least when immature osteoblasts 
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become early mature  osteoblasts50 as general consensus allows. Beyond this time point, views on the expression 
of RUNX2 and its role in mature osteoblasts are  controversial45,46,49.
Interestingly a small numbers of fHObs were observed to be able to attach to plasma treated, uncoated HSA-
DMEM/F12 hydrogels but these were not able to proliferate. This may be explained by the weak non-specific 
binding of cell surface receptors or proteins to the functional groups on HSA-DMEM/F12 hydrogels generated 
by plasma treatment. Conversely, when basement membrane proteins are added to these plasma-treated sur-
faces, they may bind to the functional groups on the basal surface, and present protein binding domains on the 
apical surface to facilitate better cell attachment and cellular responses e.g. through integrin binding sites and 
its downstream pathways.
Lastly, this study had several limitations. All biomarkers used in this study are not specific to bone tissue 
since elevated levels can be found in, but not limited to, brain and gastrointestinal tissue (https ://www.prote inatl 
as.org). Specific biomarkers for human bone (and osteoblasts) do not exist and the expression profile of these 
genes and proteins are widely accepted as important characteristics of osteoblast phenotypes. Although Geltrex 
is commonly used for the culture of human cells, it is derived from murine cancer matrix. Therefore, it may not 
have any significant physiological relevance to bone development in humans. Laminins and collagens, which are 
found in abundance in human bone marrrow, are also constituents of Geltrex. As the primary objective of this 
study was to demonstrate the functionalisation of inert albumin hydrogels with extracellular matrix proteins 
using air plasma treatment, the use of Geltrex in this context was considered appropriate. In future experiments, 
now that proof-of-concept has been established, the authors will create 3D xeno-free constructs using recombi-
nant human laminins, collagen, HSA hydrogels and co-cultures to determine the likeness of matrix-enhanced 
osteoblasts compared with patient-derived adult primary osteoblasts using in vitro and in vivo functional assays.
conclusions
In summary, this study has shown that it is possible to obtain translucent and mechanically stable heat-derived 
HSA hydrogels which can be functionalised with protein matrices through air plasma treatment. These scaf-
folds can readily support cell culture for biomedical research. Future research is required to study the effect of 
xeno-free albumin constructs in humanised animal models and determine its suitability in clinical applications 
such as cell therapy.
Materials and methods
Hydrogel synthesis. Human albumin (Sigma A1653) was dissolved in either deionized water, DBPS 
(Sigma, D8537), or DMEM/F12 (Fisher Scientific, 11574546). DMEM/F12 was supplemented with 1% Penicil-
lin/Streptomycin (Sigma TMS-AB2-C). Human albumin dissolved in DMEM/F12 pre-warmed to 37 °C to make 
up a 10% (w/v) human albumin solution was used for in vitro experiments. Once filtered, a small volume from 
a sterile stock solution of 5 M NaCl (Sigma, S5886) was added to the 10% HSA to raise the molarity of NaCl 
by 30 mM, giving a final approximate NaCl molarity of 150 mM. The solution was then syringe filtered with a 
0.1 µm syringe filter (Millipore SLVV033RS) for sterility.
Depending on the experiments, the final solution was added to either 96 well plates (Falcon 351172, 50 µl 
solution added) or 4 well plates (Thermoscientific 179830, 500 µl solution added) and sealed with aluminium 
plate sealers (Greiner Bio-One, 676090). Samples were then transferred into an oven and the temperature was 
raised to 73 °C. Samples were left for 4 h to gel and at the end of the heating process, translucent HSA hydrogels 
were obtained.
Air plasma treatment and functionalisation. Hydrogels were transferred immediately into a plasma 
cleaner (Harrick Plasma, PDC-002) after 4  h of heating. Without letting the hydrogel cool, vacuum suction 
was applied to the chamber for 3 min and high intensity (29.6 W) plasma treatment was then initiated and 
applied for 2 min under a low inflow of air. Thereafter, well plates containing the treated hydrogels were sealed 
until ready for use. Note: Plasma treatment causes a rapid reduction in the temperature of the hydrogel, which 
through ice crystal formation, yields a macroporous gel and makes the visualisation of cells difficult. This is fur-
ther exacerbated by extended plasma treatment times.
For functionalisation of HSA hydrogels with basement membrane proteins, Geltrex (Life Technologies, 
A1413302) was used. HSA hydrogels prepared above were first washed with PBS; 500 µl per well for a 4-well 
plate and 100 µl per well for a 96 well plate. After the aspiration of PBS, Geltrex diluted in DMEM/F12 to a con-
centration of 2 mg/ml was then added at a volume of 500 µl per well for a 4-well plate and 50 µl per well for a 96 
well plate. Samples were then left in the incubator at 37 °C for two hours for surface coating.
Measurement of Young’s modulus. The Young’s modulus (E) of the albumin hydrogels was measured 
in compression using a modified ‘see-saw’  method51. The two arms of the see-saw were first balanced before 
testing. Counterweights were then added onto the free-extending arm to match the height of the loading platen 
with the sample height. The load was ramped up at a constant rate of  10–3 N s−1, by pumping liquid via a syringe 
pump (PHD ULTRA Harvard Apparatus) into a container fixed on top of the loading platen. The resulting dis-
placement was monitored using a biaxial laser micrometer (Keyence, TM-040). Data analysis was conducted in 
MATLAB (MathWorks). Nominal stresses (σ) and strains (ε) were plotted, and a line was least square fitted to 
the data points, which gave an apparent E in compression. 4 samples were tested for each group to calculate the 
mean and standard error of E.
cell culture. A human fetal osteoblast cell line obtained from the Cell Applications Inc. (406K-05f) was 
used. Cells were maintained in McCoy’s 5A medium (Gibco, 16600082) which was supplemented with heat-
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inactivated 10% FBS (Invitrogen, 10108-157), 1% Antibiotic-Antimycotic (Gibco, 15240062), 50  mg/ml 
L-Ascorbic Acid Phosphate and Magnesium Salt (Fujifilm Wako Chemical corporation, 013-19641). As a com-
parison for immuno-staining, clinical grade human embryonic stem cell (hESC) line KCL-033, a kind gift from 
Dr Tamir Rashid (King’s College London), was used. hESCs were deemed a good comparison because of its low 
actin and vinculin expression on compliant  substrates22,24,25. hESCs were cultured on Geltrex and maintained in 
mTESR Plus media (Stemcell Technologies, 05825) supplemented with 1% penicillin and streptomycin (Sigma, 
TMS-AB2-C). Accutase (Sigma, A6964) was used to detach both the fHObs and hESCs for passaging and seed-
ing. Passage 3–5 fHObs and passage 25–30 hESCs were used for all experiments. Seeding densities were 40,000 
cells per well in a 96 well plate or 400,000 cells per well in a 4 well plate.
Scanning electron microscopy (SEM). Plasma treated and non-treated HSA hydrogel samples were pre-
pared for SEM by first fixing in 10% formalin (VWR International, 11699455) under a fume hood overnight. 
Samples were then thrice washed with PBS before being dehydrated in increasing concentrations of ethanol:DI 
mixtures; 30, 50, 70, 80, 90, 95 and 100% ethanol. The last step involving 100% ethanol was repeated twice. Sam-
ples were submerged in each ethanol:DI mixture for 30 min. For drying, dehydrated samples were submerged 
in increasing concentrations of hexamethyldisilazane (HMDS):ethanol mixtures under a fume hood; 33.3, 66.6 
and 100% HMDS respectively. Samples were submerged in each HMDS:ethanol mixture for 40 min and the last 
step involving 100% HMDS was repeated twice. Samples were left submerged in 100% HMDS overnight in a 
fume hood until completely dry the following day. After drying, samples were gold plated prior to imaging. The 
surface morphology of the samples was observed using a Zeiss Evo LS 15 scanning electron microscope.
Surface roughness measurements. Surface roughness was measured using a Veeco Wyko NT3300 opti-
cal profiler and interferometer. Multiple surface roughness measurements were made on plasma treated and 
non-plasma treated HSA-DMEM/F12 hydrogels using a × 10 objective. Reconstructed topographical images of 
the hydrogel surfaces were subsequently obtained.
Immunofluorescent staining. Firstly, biological samples were fixed with 4% (w/v) paraformaldehyde 
(Sigma, 252549) for 20 min at 4 °C then washed twice with PBS. A permeabilizing and blocking solution com-
prising 0.1% Triton X-100 (Sigma, T878), 0.1% TWEEN-20 (Sigma, 125 P6585) and 1% w/v BSA (Sigma, A2153) 
dissolved in PBS was then added to the samples and left for 30 min at room temperature. 3% donkey serum was 
added to the blocking solution for unconjugated antibodies (anti-vinculin).
Conjugated FITC-labelled phalloidin (Sigma, P5282) at a dilution of 1:100 was added and left at room tem-
perature for 2 h to visualise cytoplasmic actin. Samples were then washed twice with PBS and NucBlue (Invit-
rogen R37606) was added to visualise cell nuclei. Samples were left for 30 min before images were acquired. To 
visualise cytoplasmic vinculin, mouse anti-human vinculin primary antibody (Sigma, V9131) was diluted to 
1:100 and added to blocked samples for 2 h at room temperature. Subsequently, two washes with PBS were done 
and donkey anti-mouse Alexa Fluor 647 secondary antibody (Sigma, A32787) diluted to 1:1,000 was added. 
Samples were left for another 2 h at room temperature then washed twice with PBS. NucBlue (Invitrogen R37606) 
was added and samples were left for 30 min before images were acquired.
Image acquisition and image analysis. After the staining process was complete, images were acquired 
by the high content screening system Opera Phenix (Perkin Elmer). Image acquisition settings were fixed at 95% 
excitation and 200 ms exposure. Harmony high-content analysis (HCA) software version 4.9 (Perkin Elmer, 
HH17000010) was used to measure the fluorescent intensities of cytoplasmic actin and vinculin, and the mean 
fluorescent intensity was calculated.
cell proliferation analysis. Fold increase was determined by the total number of cells per well at Day 6 
 (C6) divided by the total number of cells seeded per well at Day 0  (C0):  C6 ÷ C0. Cells were counted manually on 
Day 0 before seeding. Cells were counted by imaging (Harmony HCA software version 4.9) on Day 6.
Real‑time polymerase chain reaction (Rt‑pcR). Briefly, a previously described protocol was  used52. 
According to the manufacturer’s directions, complementary deoxyribonucleic acid (cDNA) was synthesised 
by reverse transcriptase–polymerase chain reaction (RT-PCR) by using QuantiTect Reverse Transcription Kits 
(Qiagen, 205311) from RNA extracted from fHObs cultured on plasma treated and non-plasma treated hydro-
gels at day 8 of cell culture; RNeasy Protect Mini Kit (Qiagen, 74124). Expression of osteoblast genes was quanti-
fied using the QuantiFast SYBR Green PCR Kit (Qiagen, 204056) with Glyceraldehyde 3-phosphate dehydro-
genase (GADPH), human alkaline phosphates (ALP), collagen type 1α1 (COL1A1), osteocalcin (OCN) and 
runt-related transcription factor 2 (RUNX2) primers, with GADPH serving as an internal control.The following 
amplification protocol was used: activation for 5 min at 95 °C, 40 cycles at 95 °C for 10 s, then 60 °C for 30 min. 
Each group analysed contained 3 samples. The 2−ΔΔCT method was used to derive relative gene  expression53. The 
results have been presented as fold change in gene expression. The biological control group consisted of fHObs 
cultured on an uncoated tissue culture plate (industry standard) and harvested a day after splitting to establish a 
baseline for gene expressions at the start of the experiment.
Statistical analysis. Sample normality was tested using the Shapiro–Wilk test for continous variables where 
applicable and all tested populations followed a normal distribution. Differences between treated vs. non-treated 
hydrogels and fHObs vs. hESCs samples were compared using the two-tailed, independent t test by MedCalc 
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version 19.2.1 (MedCalc Software bv, https ://www.medca lc.org). The results are expressed as mean ± standard 
deviation except where otherwise stated. Results presented are from three or more independent experiments 
with three or more sample replicates. The threshold for statistical significance was set at a value of p < 0.05.
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